State Operations Manual (Pub. 100-07), Ch. 3 § 3242

Representative Sample Validation Surveys of Deemed

Last amended: 2014Year: 2014Length: 441 wordsOfficial source
3242 - Representative Sample Validation Surveys of Deemed Providers/Suppliers (Rev. 123, Issued: 10-03-14, Effective: 10-03-14, Implementation: 10-03-14) The deemed provider/supplier validation survey process is designed to evaluate the performance of a CMS-approved Medicare accreditation program by determining whether a provider/supplier that is deemed to be in compliance with the Medicare conditions on the basis of its accreditation and is, in fact, meeting Medicare health and safety requirements. Such validation surveys are authorized in accordance with §1864 of the Act. Moreover, CMS is required under §1875(b) of the Act to provide an annual report to Congress on the performance of all CMS-approved Medicare accreditation programs approved under Section 1865 of the Act, including a validation of the accreditation process. The SA conducts validation surveys of deemed provider/supplier types in accordance with established survey protocols for the provider or supplier type. CO selects a representative sample of deemed providers and suppliers for the SA to conduct a validation survey and forwards this listing each month to the ROs. Upon receipt of the monthly list, the RO electronically issues the applicable Form CMS 2802, depending on the type of provider or supplier, promptly to the SA via the ACO system deeming tab in the recertification/validation kit. The RO also provides CO via the designated Sharepoint site a copy of the Form CMS 2802 once it is issued, for tracking purposes. The representative sample validation survey is a standard, i.e. full, survey of ALL conditions applicable to that provider or supplier type. Unless the survey is a mid-cycle survey (see below), representative sample validation surveys must be conducted within 60 calendar days following the scheduled end date of the accreditation organization survey. The CO advises the RO of the AO scheduled survey end date, and the RO shares this information with the SA via the electronic version of the applicable Form CMS 2802. The SA must not share this information with any outside parties. The SA must also not request a copy of the AO survey report from the AO, in order to avoid bias in the SA’s conduct of an independent survey of the provider or supplier. In addition to the traditional representative sample validation surveys, the CO sample selection may include deemed facilities at various points in their accreditation cycle (e.g., mid-cycle). Generally the assignment of such surveys is not tied to the timing of a scheduled AO survey, and thus there is no AO survey end date that determines the timing of the SA’s validation survey. The CO will include any additional instructions (if applicable) for the conduct of such surveys, including the timeframe for completion of the survey by the SA.